J7320 is the HCPCS code for: Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg. In 2024, 347 providers billed J7320 3,633,116 times, with an estimated $15.4M paid by Medicare.
J7320 is a Part B drug code: Medicare pays an ASP-based rate of $3.81 per 1 mg (2026 Q3 ASP drug pricing file). Total payment per patient depends on the dose billed.
A billed "service" on this code is one 1 mg unit, not one patient visit — that's why the service counts below run high.
What Medicare actually paid per service in 2024, on average: $4.23 (observed payment across all settings and modifiers — not a fee-schedule rate).
The top 5 billers nationally, ranked by 2024 Medicare service volume.
| # | Provider | Specialty | Location | Services | Est. Medicare paid |
|---|---|---|---|---|---|
| 1 | Rahul Khapekar, D.O. | Family Practice | Park Ridge, IL | 308,602 | $1.3M |
| 2 | Robert Streisand, M.D. | Vascular Surgery | Pelham, NY | 132,926 | $558K |
| 3 | Hubert Franke, M.D. | General Practice | Wall, NJ | 132,250 | $556K |
| 4 | Ermin Arriola, M.D. | Physical Medicine and Rehabilitation | Morton Grove, IL | 131,800 | $564K |
| 5 | Nicholas Manolitsis, MD | Physical Medicine and Rehabilitation | Chicago, IL | 111,328 | $477K |
Prospect 811 answers "what is this code, what does it pay, and who bills it?" for every billable code — then filters the answer to your exact territory, with phone numbers. $79/month, no contract, 14-day refund.
Start prospecting →